Free. Unsubscribe any time.
Pacira BioSciences, Inc. (PCRX)
Pacira BioSciences, Inc. filed 14 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 5 reporting owners, covering 17 transactions and 110,481 shares. None carries the SEC's AFF10B5ONE flag; all 14 name a plan in a footnote. 9 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-08-18, came 67 days after the one before it (2026-06-12) and reports 1 transaction against 1 in the filing before it.
- The sales it reports total 3,040 shares, 3,075 fewer than the 6,115 in the filing before it.
- Its 14 plan statements rank 335th of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 4 have more plan statements on file than it and 6 have fewer.
- Its 14 filings on file run from 2025-01-06 to 2026-08-18, and state 4 plan adoption dates, from 2025-06-09 to 2026-03-12.
Trades in Pacira BioSciences, Inc. 17
- SLONIN JONATHAN — 2025-01-06 · S · 879 shares
- Ceesay Abraham — 2025-09-04 · S · 2,354 shares
- Cross Shawn — 2025-11-10 · S · 12,060 shares
- SLONIN JONATHAN — 2025-11-17 · S · 3,960 shares
- Cross Shawn — 2025-12-09 · S · 15,896 shares
- Cross Shawn — 2025-12-10 · S · 9,104 shares
- RIKER LAUREN — 2026-01-05 · S · 1,416 shares
- RIKER LAUREN — 2026-02-02 · S · 4,000 shares
- WILLIAMS KRISTEN — 2026-02-02 · S · 13,137 shares
- SLONIN JONATHAN — 2026-03-17 · S · 3,261 shares
- Cross Shawn — 2026-04-20 · S · 7,714 shares
- Cross Shawn — 2026-04-21 · S · 2,845 shares
Adoption dates in Pacira BioSciences, Inc. 4
- 2025-06-09 — stated in 2 filings
- 2025-08-12 — stated in 2 filings
- 2025-09-10 — stated in 1 filing
- 2026-03-12 — stated in 1 filing
Results prints in Pacira BioSciences, Inc. 9
- 2025-01-10
- 2025-02-27
- 2025-05-08
- 2025-08-05
- 2025-11-06
- 2026-01-08
- 2026-02-26
- 2026-04-30
- 2026-08-04
Trades before a print in Pacira BioSciences, Inc. 2
- 3 days before the 2026-01-08 print — 2026-01-05 · S · RIKER LAUREN · 1,416 shares
- 4 days before the 2025-01-10 print — 2025-01-06 · S · SLONIN JONATHAN · 879 shares
- 7 days before the 2026-04-30 print — 2026-04-23 · S · Cross Shawn · 12,941 shares
- 8 days before the 2026-04-30 print — 2026-04-22 · S · Cross Shawn · 1,500 shares
- 9 days before the 2026-04-30 print — 2026-04-21 · S · Cross Shawn · 2,845 shares
- 10 days before the 2026-04-30 print — 2026-04-20 · S · Cross Shawn · 7,714 shares
- 24 days before the 2026-02-26 print — 2026-02-02 · S · RIKER LAUREN · 4,000 shares
- 24 days before the 2026-02-26 print — 2026-02-02 · S · WILLIAMS KRISTEN · 13,137 shares
- 29 days before the 2026-01-08 print — 2025-12-10 · S · Cross Shawn · 9,104 shares
- 30 days before the 2026-01-08 print — 2025-12-09 · S · Cross Shawn · 15,896 shares
- 44 days before the 2026-04-30 print — 2026-03-17 · S · SLONIN JONATHAN · 3,261 shares
- 52 days before the 2026-01-08 print — 2025-11-17 · S · SLONIN JONATHAN · 3,960 shares
Interval to Pacira BioSciences, Inc.’s next reported results date
How the interval and sources are counted →
- 2within 5 days
- 6within 10 days
- 3shortest, days
- 1no later print
- SLONIN JONATHAN 2025-01-06 · S · 4 days before the 2025-01-10 print · Chief Medical Officer
- RIKER LAUREN 2026-01-05 · S · 3 days before the 2026-01-08 print · Senior Vice President, Finance
- Cross Shawn 2026-04-20 · S · 10 days before the 2026-04-30 print · Chief Financial Officer
- Cross Shawn 2026-04-21 · S · 9 days before the 2026-04-30 print · Chief Financial Officer
- Cross Shawn 2026-04-22 · S · 8 days before the 2026-04-30 print · Chief Financial Officer
- Cross Shawn 2026-04-23 · S · 7 days before the 2026-04-30 print · Chief Financial Officer
Adoption dates Pacira BioSciences, Inc. states
- 2025-06-09 in 2 filings
- 2025-08-12 in 2 filings
- 2025-09-10 in 1 filing
- 2026-03-12 in 1 filing
Filing text: “10b5-1 trading plan was adopted on August 12, 2025”
Reported results dates on file
- 2025-01-10
- 2025-02-27
- 2025-05-08
- 2025-08-05
- 2025-11-06
- 2026-01-08
- 2026-02-26
- 2026-04-30
- 2026-08-04
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.